348 related articles for article (PubMed ID: 31053500)
21. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
23. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
24. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
25. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.
ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE
Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
28. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma.
Shen X; Xue Y; Cong H; Wang X; Ju S
Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698
[TBL] [Abstract][Full Text] [Related]
30. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
31. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
32. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
33. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
34. A Potential Serum
Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis.
Guo X; Lv X; Lv X; Ma Y; Chen L; Chen Y
Oncotarget; 2017 Jul; 8(27):44050-44058. PubMed ID: 28477010
[TBL] [Abstract][Full Text] [Related]
38. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
[TBL] [Abstract][Full Text] [Related]
39. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
40. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]